Correction to: MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus

  • Julia Slotta-Huspenina
  • Enken Drecoll
  • Marcus Feith
  • Daniel Habermehl
  • Stephanie E. Combs
  • Wilko Weichert
  • Marcus Bettstetter
  • Karen Becker
  • Rupert Langer
Open Access
Correction

Correction to: J Transl Med (2018) 16:109  https://doi.org/10.1186/s12967-018-1492-9

Following publication of the original article [1], the authors reported that for one of the authors, Stephanie E. Combs, the middle name was accidentally omitted. They also reported that for two of the authors, Daniel Habermehl and Stephanie E. Combs, two affiliations were accidentally omitted. In this Correction the incorrect and correct author name are shown and the two omitted affiliations are listed.

Originally the author name has been published as:
  • Stephanie Combs

The correct author name is:
  • Stephanie E. Combs

The two missing affiliations for Daniel Habermehl and Stephanie E. Combs are:
  • Department of Radiation Sciences (DRS), Institute of Innovative Radiotherapie (iRT), Helmholtz Zentrum München, Ingolstädter Landstrasse 1, 85764 Neuherberg, Germany.

  • Deutsches Konsortium für Translationale Krebsforschung (DKTK), Partner Site Munich, Munich Germany.

The complete list of affiliations is included in this Correction.

Notes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Reference

  1. 1.
    Slotta-Huspenina J, Drecoll E, Feith M, Habermehl D, Combs SE, Weichert W, Bettstetter M, Becker K. MicroRNA expression profiling for the prediction of resistance to neoadjuvant radiochemotherapy in squamous cell carcinoma of the esophagus. J Transl Med. 2018;16:109.  https://doi.org/10.1186/s12967-018-1492-9.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Author(s) 2018

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors and Affiliations

  • Julia Slotta-Huspenina
    • 1
  • Enken Drecoll
    • 1
  • Marcus Feith
    • 2
  • Daniel Habermehl
    • 3
    • 4
    • 5
  • Stephanie E. Combs
    • 3
    • 4
    • 5
  • Wilko Weichert
    • 1
  • Marcus Bettstetter
    • 6
  • Karen Becker
    • 1
  • Rupert Langer
    • 7
  1. 1.Institute of PathologyTechnische Universität MünchenMunichGermany
  2. 2.Department of SurgeryKlinikum Rechts der Isar, Technische Universität MünchenMunichGermany
  3. 3.Department of Radiation OncologyKlinikum Rechts der Isar, Technische Universität MünchenMunichGermany
  4. 4.Department of Radiation Sciences (DRS)Institute of Innovative Radiotherapie (iRT)NeuherbergGermany
  5. 5.Deutsches Konsortium für Translationale Krebsforschung (DKTK)MunichGermany
  6. 6.Teilgemeinschaftspraxis Molekularpathologie SüdbayernMunichGermany
  7. 7.Institute of PathologyUniversity of BernBernSwitzerland

Personalised recommendations